Description
SofosbuvirisanantiviralcompoundthatinhibitsviralRNApolymerase.SofosbuvirisclinicallyusedtotreathepatitisCinfection.Thiscompoundisaprodrugthatismetabolizedtoamoreactiveintermediate.
SofosbuvirisanantiviralcompoundthatinhibitsviralRNApolymerase.SofosbuvirisclinicallyusedtotreathepatitisCinfection.Thiscompoundisaprodrugthatismetabolizedtoamoreactiveintermediate.
| CasNo. | 1190307-88-0 |
|---|---|
| Purity | ≥98% |
| Formula | C22H29FN3O9P |
| FormulaWt. | 529.45 |
| IUPACName | propan-2-yl(2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
| Appearance | Yellowtooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | S5722InfoSheetPDF |
|---|
MurakamiC,MeldaUrekliH,AttaMG.AntiviralmedicationsforthetreatmentofhepatitisBandCinfectionandtheireffectsonkidneyfunction.MinervaGastroenterolDietol.2014Sep;60(3):177-89.PMID:25027705.
FungA,JinZ,DyatkinaN,etal.Efficiencyofincorporationandchainterminationdeterminestheinhibitionpotencyof2-modifiednucleotideanalogsagainsthepatitisCviruspolymerase.AntimicrobAgentsChemother.2014Jul;58(7):3636-45.PMID:24733478.
MurakamiE,TolstykhT,BaoH,etal.MechanismofactivationofPSI-7851anditsdiastereoisomerPSI-7977.JBiolChem.2010Nov5;285(45):34337-47.PMID:20801890.